APA (7th ed.) Citation

S, B., V, T., S, O., KA, B., SA, B., E, J., . . . VG, A. (2021). SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline. The Journal of infectious diseases, 223(8), 1334. https://doi.org/10.1093/infdis/jiaa796

Chicago Style (17th ed.) Citation

S, Bolotin, Tran V, Osman S, Brown KA, Buchan SA, Joh E, Deeks SL, and Allen VG. "SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline." The Journal of Infectious Diseases 223, no. 8 (2021): 1334. https://doi.org/10.1093/infdis/jiaa796.

MLA (9th ed.) Citation

S, Bolotin, et al. "SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline." The Journal of Infectious Diseases, vol. 223, no. 8, 2021, p. 1334, https://doi.org/10.1093/infdis/jiaa796.